뉴스
-
Broker Call Lifts Qurient, AbClon, L&C Bio Rebounds on Rights Offering[K-Bio Pulse]
South Korea's Kosdaq market closed higher on Tuesday, supported by net buying from foreign and institutional investors, while most pharmaceutical and biotechnology stocks also gained.
www.edaily.co.kr · 2026.08.05
-
Onconic Surges on Jaqbo’s India Approval[K-Bio Pulse]
South Korea’s pharmaceutical and life sciences sectors advanced in tandem on Aug. 6, led by Onconic Therapeutics, Qurient and Voronoi.The pharmaceutical index gained 2.24%, with 97 of 161 stock...
www.edaily.co.kr · 2026.08.07
-
U.S. approves potential sale to S. Korea of AIM-9X air-to-air missiles
government has authorized a potential sale to South Korea of AIM-9X air-to-air missiles and related equipment
en.yna.co.kr · 2026.08.21
-
U.S.-N. Korea talks key to breaking stalemate: Seoul official
South and North Korea remain technically at war, as the 1950-53 Korean War ended with an armistice.
en.yna.co.kr · 2026.08.21
-
Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse]
On July 31, South Korean pharmaceutical and biotech stocks broadly advanced as domestic equities rebounded , with bargain hunting returning to beaten-down growth and biotech names.
www.edaily.co.kr · 2026.08.01
-
FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls...
On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded.
www.edaily.co.kr · 2026.08.11
-
Deepnoid and Peptron Hit Daily Limit, L&C Bio Falls on Rights Offering[K-Bio Pulse]
South Korea's pharmaceutical and biotechnology sector received a boost on Aug. 3 as the KOSDAQ market
www.edaily.co.kr · 2026.08.04
-
i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse]
South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting
www.edaily.co.kr · 2026.07.28
-
HLB Hits Limit-Up on FDA Optimism; Curiosis, Peptron Rebound Sharply [K-Bio Pulse]
On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates , while Curiosis and Peptron posted double-digit gains.Investor sentiment was boosted by rene...
www.edaily.co.kr · 2026.07.16
-
Diagnostics Rally Despite Kolon TissueGene Trial Shock[K-Bio Pulse]
Investor sentiment across South Korea’s pharmaceutical and life sciences sectors remained weak
www.edaily.co.kr · 2026.07.23
